These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs. Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279 [TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
7. Preliminary pharmacokinetics of a new pyridopyrimidine derivative. Pérez MJ; Roch MJ; Ochoa MC Arzneimittelforschung; 1991 Jun; 41(6):640-4. PubMed ID: 1930354 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of higenamine in rabbits. Lo CF; Chen CM Biopharm Drug Dispos; 1996 Dec; 17(9):791-803. PubMed ID: 8968531 [TBL] [Abstract][Full Text] [Related]
11. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin. Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats. Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males. Huang SM; Brusser L; Chien SC; Simon D; Smith IL; Abrams LS; Lasseter K Int J Clin Pharmacol Ther; 1994 Feb; 32(2):62-4. PubMed ID: 8004360 [TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats. Matsumoto S; Tagawa M; Hatoyama T; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677 [TBL] [Abstract][Full Text] [Related]
15. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of tolmetin in the rat. Sabater J; Domenéch J; Obach R Arzneimittelforschung; 1992 Jul; 42(7):950-3. PubMed ID: 1418060 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421 [TBL] [Abstract][Full Text] [Related]
20. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA; Prakash C Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]